Key facts
- It has raised $52.5M across 1 recorded rounds; the latest was Seed Round in Jan 2021.
- Notable investors include Y Combinator, Alumni Ventures, Pioneer Fund, Mana Ventures, Gaingels — 50 tracked in total.
- Status: Privately Held (backing).
- ·Post-money valuations for all 1 rounds
- ·The complete investor list — 50 names
- ·Watchlist + deal alerts for HelixNano
Funding rounds
1 roundsAbout HelixNano
Operator of a native biotechnology company intended to enable previously impossible applications across human and non-human biology. The company's platform uses artificial intelligence to leverage synthetic biology to safely and reliably express transgenes in humans for next-generation gene therapies, genome engineering, and beyond, allowing clinicians to treat patients suffering from various diseases.
- Industry
- Biotechnology
- Sector
- Healthcare
- HQ
- Boston, MA, United States
- Founded
- 2013
- Employees
- 27
- Website
- helixnano.com/
- Ownership
- Privately Held (backing)
HelixNano doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in HelixNano shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on HelixNano in its N-PORT filings yet. We sweep new filings monthly.